Clinical study—III
The contributions of sympathetic tone and the renin-angiotensin system to severe chronic congestive heart failure: Response to specific inhibitors (prazosin and captopril)

https://doi.org/10.1016/0002-9149(82)90244-2Get rights and content

Abstract

The contribution of sympathetic tone and the renin-angiotensin system to the pathogenesis of chronic heart failure was evaluated. In 20 paired studies of the same 10 patients, the baseline hemodynamic and humoral correlates of congestive heart failure, and the response to alpha adrenergic blockade (prazosin) and angiotensin converting enzyme inhibition (captopril) were assessed. Despite the extent of failure, baseline plasma renin activity ranged from normal to very high. In contrast, baseline plasma catecholamlne levels were always elevated. Baseline plasma norepinephrine reflected the severity of heart failure, correlating inversely with baseline cardiac index before administration of both drugs. Comparable improvement in left ventricular function was noted after acute therapy. Baseline renin and norepinephrine did not predict the response to prazosin, but baseline renin did predict the response to captopril: pulmonary wedge pressure (r = −0.776, p < 0.01), stroke index (r = 0.752, p < 0.02), systemic vascular resistance (r = −0.673, p < 0.05).

In summary, elevated levels of plasma norepinephrine were inversely correlated with baseline cardiac function, but norepinephrine levels did not change despite improved hemodynamics with specific prazosin therapy. The renin-angiotensin system exhibited a wide spectrum of activity and hemodynamic improvement with captopril was related to this activity. Absence of a correlation between plasma norepinephrine and plasma renin activity suggested that their contributions to vasoconstriction were not interdependent. Increased sympathetic tone was consistent in severe heart failure, whereas renin-angiotensin activity differed widely. The response to captopril can be used to identify a subset of patients with severe heart failure and adverse angiotensin-mediated vasoconstriction.

References (39)

  • EH Sonnenblick et al.

    Afterload as a primary determinant of ventricular performance

    Am J Physiol

    (1963)
  • TW Smith et al.

    The management of heart failure

  • PA Majid et al.

    Phentolamine for vasodilator treatment of severe heart failure

    Lancet

    (1971)
  • L Watkins et al.

    The renin-angiotensin-aldosterone system in congestive failure in conscious dogs

    J Clin Invest

    (1976)
  • GA Turini et al.

    Congestive heart failure in normotensive man: haemodynamics, renin, and angiotensin II blockade

    Br Heart J

    (1978)
  • C Curtiss et al.

    Role of the reninangiotensin system in the systemic vasoconstriction of chronic congestive heart failure

    Circulation

    (1978)
  • RR Miller et al.

    Sustained reduction of cardiac impedance and preload in congestive heart failure with the antihypertensive vasodilator prazosin

    N Engl J Med

    (1977)
  • SB Arnold et al.

    Attenuation of prazosin effect on cardiac output in chronic heart failure

    Ann Intern Med

    (1979)
  • M Packer et al.

    Hemodynamic and clinical tachyphylaxis to prazosin-mediated afterload reduction in severe chronic congestive heart failure

    Circulation

    (1979)
  • Cited by (0)

    View full text